DexCom Inc. (DXCM)
DXCM trades on Nasdaq in Health Care, Medical/Dental Instruments. Numbers below come from the Nasdaq screener and SEC filings, each with its source.
Price · October 14, 2026
$85.06
-1.00% on the day
Market cap
$32.1B
Large cap
Revenue · 2025
$4.7B
+15.6% on 2024
Net income · 2025
$836.3M
17.9% net margin
Price, change, market cap, sector and industry: Nasdaq stock screener, as of October 14, 2026. Revenue: SEC XBRL frames, calendar 2025.
Profile
| Field | Value |
|---|---|
| Ticker | DXCM on Nasdaq |
| Sector | Health Care |
| Industry | Medical/Dental Instruments |
| Country | United States |
| IPO year | 2005 |
| SEC CIK | 0001093557 |
| SEC industry code | Surgical & Medical Instruments & Apparatus |
| Incorporated in | DE |
Financials · 2025
| Line | Value |
|---|---|
| Revenue | $4.7B |
| Net income | $836.3M |
| Operating income | $911.8M |
| Net margin | 17.9% |
| Operating margin | 19.6% |
| Revenue growth | +15.6% |
| Cash | $917.7M |
| Total assets | $6.3B |
| P/E (computed) | 38.4× |
| P/S (computed) | 6.9× |
Key SEC documents
| Document | Form | Filed |
|---|---|---|
| Latest prospectus or offering document | S-3ASR | 2025-02-18 |
| Latest annual report | 10-K | 2026-02-12 |
| Latest quarterly / interim | 10-Q | 2026-07-30 |
| Latest current report | 8-K | 2026-09-14 |
| Latest proxy | DEFA14A | 2026-04-15 |
Source: SEC EDGAR submissions feed, 1,002 recent filings. All filings on EDGAR.
Price moves
| Window | Return |
|---|---|
| 1 week | -0.8% |
| 1 month | -3.2% |
| 3 months | +7.3% |
| Year to date | +26.0% |
| 1 year | +28.3% |
| From 52-week high | -9.4% |
Source: Yahoo Finance daily closes, last bar 2026-10-14. Computed by Sophia Capital from daily closes; cap, sector and tier from the Nasdaq screener.
Peers in Medical/Dental Instruments
| Ticker | Company | Price | Day | Market cap |
|---|---|---|---|---|
| RMD | ResMed Inc. | $235.04 | +0.19% | $33.1B |
| WST | West Pharmaceutical Services Inc. | $371.82 | +1.15% | $26.2B |
| MDLN | Medline Inc. | $35.70 | -0.17% | $46.9B |
| BDX | Becton Dickinson and Company | $187.37 | -0.81% | $51.0B |
| BSX | Boston Scientific Corporation | $43.31 | -1.21% | $62.8B |
| SOLV | Solventum Corporation | $86.30 | +1.16% | $14.7B |
| BAX | Baxter International Inc. | $24.89 | +0.44% | $12.9B |
| PEN | Penumbra Inc. | $320.01 | -0.30% | $12.6B |
The full dossier has every filing, three years of financials, private raises and the people who signed them.
Open the full dossier